
Martin Shkreli, his former company thwarted generic competition against toxoplasmosis drug, FTC says
In charges announced Monday, the agency says Vyera Pharmaceuticals - formerly Turing Pharma - used deals with distributors to prevent generic companies from obtaining samples and sales data for Daraprim. Vyera called the charges meritless.